The unadjusted median time to symptom resolution was 10 days in both the intervention and placebo groups.
Montelukast didn’t cut time to COVID symptom relief in clinical trial
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- US flu season shows signs of peak
- Hospitalized COVID patients at higher risk for organ-related death, readmission for 2.5 years, data suggest
- Liberals’, conservatives’ trust in US government’s use of digital health data diverged during COVID
- Report: COVID survivors nearly twice as likely to have ongoing symptoms as those with flu